mhurhangee/ep-ind-claims huggingface dataset:
A modified conjugated diene-based polymer comprising a repeating unit derived from a conjugated diene-based monomer and a repeating unit derived from a modification monomer represented by the following Formula 1: in Formula 1, R 1 is a divalent hydrocarbon group of 1 to 10 carbon atoms, or a linker represented by Formula 2, R 2 to R 5 are each independently hydrogen or a monovalent hydrocarbon group of 1 to 10 carbon atoms, and one or more of R 1 to R 5 are required to be a hydrocarbon group including a carbon-carbon unsaturated bond, where if R 2 to R 5 do not include the unsaturated bond, R 1 is required to be a linker represented by the following Formula 2: in Formula 2, R 10 and R 11 are each independently a single bondor a divalent hydrocarbon group of 1 to 5 carbon atoms, R 12 and R 13 are each independently hydrogen or a monovalent hydrocarbon group of 1 to 5 carbon atoms, wherein the repeating unit derived from the modification monomer is included in an amount from 0.01 wt% to 10 wt% based on the total weight of the repeating unit derived from each monomer which constitutes the modified conjugated diene-based polymer, and the repeating unit derived from the modification monomer is comprised in a terminal part of the modified conjugated diene-based polymer. R 1 is a divalent hydrocarbon group of 1 to 10 carbon atoms, or a linker represented by Formula 2, R 2 to R 5 are each independently hydrogen or a monovalent hydrocarbon group of 1 to 10 carbon atoms, and one or more of R 1 to R 5 are required to be a hydrocarbon group including a carbon-carbon unsaturated bond, where if R 2 to R 5 do not include the unsaturated bond, R 1 is required to be a linker represented by the following Formula 2: in Formula 2, R 10 and R 11 are each independently a single bondor a divalent hydrocarbon group of 1 to 5 carbon atoms, R 12 and R 13 are each independently hydrogen or a monovalent hydrocarbon group of 1 to 5 carbon atoms, wherein the repeating unit derived from the modification monomer is included in an amount from 0.01 wt% to 10 wt% based on the total weight of the repeating unit derived from each monomer which constitutes the modified conjugated diene-based polymer, and
A feedthrough configured to facilitate passage of a cable through an opening of a hull, comprising: a. a guide configured for (i) surrounding at least a portion of the opening and (ii) guiding the cable in a non-linear path to or from the opening; and b. a cover plate configured for attaching to the guide; characterised in that the guide has a spirally-curved cross-section. a. a guide configured for (i) surrounding at least a portion of the opening and (ii) guiding the cable in a non-linear path to or from the opening; and b. a cover plate configured for attaching to the guide; characterised in that the guide has a spirally-curved cross-section.
A aTh1 composition for use in treating a patient with HIV comprising: increasing the titer of circulating CD4+ Th1 memory cells that are resistant to HIV infection by administering at least one intradermal dose to the patient; and expanding and activating the CD4+ Th1 memory cells in the patient by administering at least one intravenous dose. increasing the titer of circulating CD4+ Th1 memory cells that are resistant to HIV infection by administering at least one intradermal dose to the patient; and expanding and activating the CD4+ Th1 memory cells in the patient by administering at least one intravenous dose.
An electronic smoking article comprising: a casing extending in a longitudinal direction; a heater element configured to generate a vapor, the heater element within the casing; a power supply configured to supply power to the heater element; a mouth-end insert at an end of the casing, the mouth-end insert including an on-axis outlet centrally located in the mouth-end insert, characterized in that the mouth end insert further comprises at least two outlets uniformly spaced about a perimeter of the mouth-end insert, the at least two outlets configured to distribute the vapor exiting the electronic smoking article; wherein the electronic smoking article further comprises a downstream gasket, wherein the downstream gasket includes a central channel disposed between a central passage of an inner tube and the interior of the mouth-end insert, wherein the central channel is configured to substantially prevent acceleration of the vapor approaching the mouth-end insert. a casing extending in a longitudinal direction; a heater element configured to generate a vapor, the heater element within the casing; a power supply configured to supply power to the heater element; a mouth-end insert at an end of the casing, the mouth-end insert including an on-axis outlet centrally located in the mouth-end insert, characterized in that the mouth end insert further comprises at least two outlets uniformly spaced about a perimeter of the mouth-end insert, the at least two outlets configured to distribute the vapor exiting the electronic smoking article; wherein the electronic smoking article further comprises a downstream gasket, wherein the downstream gasket includes a central channel disposed between a central passage of an inner tube and the interior of the mouth-end insert, wherein the central channel is configured to substantially prevent acceleration of the vapor approaching the mouth-end insert.
Chassis for a vehicle, comprising: - a core having an elongate shape with a length, greater than a width, defining a longitudinal direction, - a plate referred to as the upper plate, of which the surface substantially corresponds to the surface of the core, and - a plate referred to as the lower plate, of which the surface substantially corresponds to the surface of the core, the core being sandwiched between the upper plate and the lower plate while being rigidly connected thereto, the core being a core of synthetic foam and the core being reinforced by at least one first tube (24, 26) arranged longitudinally over a portion of the length of the core, characterized in that said first tube is fixed to a plate (10 or 12) of the chassis and is separated from the other plate (12 or 10) of the chassis by synthetic foam. - a core having an elongate shape with a length, greater than a width, defining a longitudinal direction, - a plate referred to as the upper plate, of which the surface substantially corresponds to the surface of the core, and - a plate referred to as the lower plate, of which the surface substantially corresponds to the surface of the core,
A transformer, comprising a transformer core, wherein the transformer core is a toroid and wherein the transformer core defines a first plane in which or in parallel to which the magnetic flux of the transformer core extends during operation of the transformer, wherein a top side and a bottom side of the transformer core extend in parallel to the first plane; a first wire that forms a first winding; a second wire that forms a second winding, wherein the first winding and the second winding (202, 203) are wound around the transformer core, wherein the transformer further comprises: a preformed insulation structure (204, 205), wherein the preformed insulation structure is situated between the first winding and the second winding (202, 203) of the transformer, and wherein the preformed insulation structure (204, 205) spaces the second winding apart from the first winding and from the transformer core, wherein the preformed insulation structure (204, 205) includes a first shell and a second shell (204, 205) that at least partially enclose the transformer core with the first winding, wherein the first shell encloses the top side, and the second shell encloses the bottom side, of the transformer core, wherein the first and second shells (204, 205) form an inner wall through a central opening in the toroid, wherein the inner wall forms a hole through which the second winding is wound, and wherein the first shell and the second shell (204; 205) each have multiple holes whose size, shape, and position are selected in such a way that an insulating substance can penetrate through the holes and into the interior of the preformed insulation structure (204; 205). a preformed insulation structure (204, 205), wherein the preformed insulation structure is situated between the first winding and the second winding (202, 203) of the transformer, and wherein the preformed insulation structure (204, 205) spaces the second winding apart from the first winding and from the transformer core, wherein the preformed insulation structure (204, 205) includes a first shell and a second shell (204, 205) that at least partially enclose the transformer core with the first winding, wherein the first shell encloses the top side, and the second shell encloses the bottom side, of the transformer core, wherein the first and second shells (204, 205) form an inner wall through a central opening in the toroid, wherein the inner wall forms a hole through which the second winding is wound, and wherein the first shell and the second shell (204; 205) each have multiple holes whose size, shape, and position are selected in such a way that an insulating substance can penetrate through the holes and into the interior of the preformed insulation structure (204; 205).
A wearable device comprising a device carrier, a device core unit, a first USB interface, a second USB interface, and a signal path selection unit, wherein • the device carrier is configured to carry the device core unit, the first USB interface, the second USB interface, and the signal path selection unit of the wearable device, so that the device is wearable; • the device core unit is configured to perform a core function of the wearable device; • the first USB interface and the second USB interface are configured to connect to an external device; • the signal path selection unit is configured to control a signal path between the first USB interface and the device core unit or a signal path between the first USB interface and the second USB interface to be connected, characterized in that • the signal path selection unit is specifically configured to: control the signal path between the first USB interface and the device core unit to be connected when the device core unit is not separated from the device carrier; and control the signal path between the first USB interface and the second USB interface to be connected when the device core unit is separated from the device carrier. • the device carrier is configured to carry the device core unit, the first USB interface, the second USB interface, and the signal path selection unit of the wearable device, so that the device is wearable; • the device core unit is configured to perform a core function of the wearable device; • the first USB interface and the second USB interface are configured to connect to an external device; • the signal path selection unit is configured to control a signal path between the first USB interface and the device core unit or a signal path between the first USB interface and the second USB interface to be connected, • the signal path selection unit is specifically configured to: control the signal path between the first USB interface and the device core unit to be connected when the device core unit is not separated from the device carrier; and control the signal path between the first USB interface and the second USB interface to be connected when the device core unit is separated from the device carrier.
A compound of the formula: wherein: R 1 is C 1 -C 5 alkyl optionally substituted with 1-3 substituents chosen from hydroxyl, C 1 -C 5 alkoxy optionally substituted with a carboxamido group and C 3 -C 6 cycloalkyl; R 2 is C 1 -C 5 alkyl, cyclopropyl, cyclopentyl, cyclohexyl, tetrahydropyranyl or piperidinyl, each optionally independently substituted with 1-2 substituents chosen from hydroxyl, C 1 -C 5 alkoxy and phenyl; R 3 is a bond, -C -NH-, -NH-C -, -CHR a -O-, -O-CH 2 -, -C -NH-CH 2 -, -CH 2 -NH-C -, SO 2 -NH- or-NH-SO 2 -; wherein R a is C 1 -C 5 alkyl; R 4 is C 1 -C 5 alkyl, C 1 -C 5 alkylamino, amino, C 1 -C 5 dialkylamino, phenylamino, cyano, halogen, nitro, C 1 -C 5 thioalkyl wherein the sulfur atom may be oxidized, C 1 -C 5 alkoxyl, -O-alkoxyl, -NH-SO 2 -, -OCH 2 -phenyl, cyclopropyl, phenyl, furanyl, thienyl, pyrazolyl, imidazolyl, pyridinyl, pyrimidinyl, imidazopyridinyl or benzofuranyl, each optionally independently substituted with 1-3 substituents chosen from C 1 -C 5 alkyl, amino, halogen, trifluoromethyl and C 1 -C 5 alkoxy; X is N or CH; and Ar is furanyl; or a pharmaceutically acceptable salt thereof. R 1 is C 1 -C 5 alkyl optionally substituted with 1-3 substituents chosen from hydroxyl, C 1 -C 5 alkoxy optionally substituted with a carboxamido group and C 3 -C 6 cycloalkyl; R 2 is C 1 -C 5 alkyl, cyclopropyl, cyclopentyl, cyclohexyl, tetrahydropyranyl or piperidinyl, each optionally independently substituted with 1-2 substituents chosen from hydroxyl, C 1 -C 5 alkoxy and phenyl; R 3 is a bond, -C -NH-, -NH-C -, -CHR a -O-, -O-CH 2 -, -C -NH-CH 2 -, -CH 2 -NH-C -, SO 2 -NH- or-NH-SO 2 -; wherein R a is C 1 -C 5 alkyl; R 4 is C 1 -C 5 alkyl, C 1 -C 5 alkylamino, amino, C 1 -C 5 dialkylamino, phenylamino, cyano, halogen, nitro, C 1 -C 5 thioalkyl wherein the sulfur atom may be oxidized, C 1 -C 5 alkoxyl, -O-alkoxyl, -NH-SO 2 -, -OCH 2 -phenyl, cyclopropyl, phenyl, furanyl, thienyl, pyrazolyl, imidazolyl, pyridinyl, pyrimidinyl, imidazopyridinyl or benzofuranyl, each optionally independently substituted with 1-3 substituents chosen from C 1 -C 5 alkyl, amino, halogen, trifluoromethyl and C 1 -C 5 alkoxy; X is N or CH; and Ar is furanyl;
A method of producing human pancreatic endocrine cells, comprising: (a) culturing human definitive endoderm cells for 3 to 5 days in a medium supplemented with fibroblast growth factor 2 (FGF-2), retinoic acid and activin A, and (b) culturing the cells for 3 to 5 days in a medium supplemented with (i) retinoic acid, or (ii) retinoic acid and FGF-2, thereby producing a population of human pancreatic endocrine cells, wherein the pancreatic endocrine cells express at least NKX2.2, and wherein the pancreatic endocrine cells are of the β-cell lineage. (a) culturing human definitive endoderm cells for 3 to 5 days in a medium supplemented with fibroblast growth factor 2 (FGF-2), retinoic acid and activin A, and (b) culturing the cells for 3 to 5 days in a medium supplemented with (i) retinoic acid, or (ii) retinoic acid and FGF-2, thereby producing a population of human pancreatic endocrine cells, wherein the pancreatic endocrine cells express at least NKX2.2, and wherein the pancreatic endocrine cells are of the β-cell lineage.
A hydraulic vane cell machine with a stator and a rotor, which has a plurality of vanes which are respectively radially displaceable in a guide in the rotor, contiguous with an internal circumference of the stator and delimit, together with the rotor, the stator and a respective side wall, working chambers at each axial end of the rotor, the volumes of which change during a rotation of the rotor in relation to the stator, wherein each vane has on its radial inner side a contact surface that is contiguous radially on the outside with a cam plate, characterized in that the contact surface is formed at at least one axial end of the vanes and the contact surface is formed in a recess at the axial end of the vane, wherein the vanes have a core made of a steel and a coating made of a plastic that interacts with low friction with steel, each vane has in the area of the guide a surface formed from a plastic that interacts with low friction with steel and the contact surface is at least partially formed from a steel and is rounded, wherein the cam plate has, at least in an area that is contiguous with the vanes, a surface formed from a plastic that interacts with low friction with steel.
A method of protecting steel in reinforced concrete, the method comprising: applying a two phase electrochemical treatment, to the steel of the reinforced concrete, in which a first phase comprises application of an initial temporary impressed current treatment to induce open circuit steel passivity and a, subsequent, phase comprises application of a sacrificial cathodic prevention treatment; wherein average current delivered to the steel during the sacrificial cathodic prevention treatment is less than 5 mA per square meter of steel. applying a two phase electrochemical treatment, to the steel of the reinforced concrete, in which a first phase comprises application of an initial temporary impressed current treatment to induce open circuit steel passivity and a, subsequent, phase comprises application of a sacrificial cathodic prevention treatment; wherein average current delivered to the steel during the sacrificial cathodic prevention treatment is less than 5 mA per square meter of steel. wherein average current delivered to the steel during the sacrificial cathodic prevention treatment is less than 5 mA per square meter of steel.
Apparatus for connecting a table to a side wall of a rail vehicle, having: - a table top, - a first connection component (3, 5, 6), which is arranged underneath an upper side (1.1) of the table top as a supporting structure and the upper end of which is fixed to the table top and the lower end of which is fixed to the side wall of the rail vehicle, wherein the first connection component (3, 5, 6) comprises two posts which are arranged upright at a distance from each other and each have a lower, first joint region and an upper, second joint region, which can be pivoted about a respective pivot axis (5.1, 6.1) and which, in relation to a state of the apparatus arranged on the side wall, are each oriented transversely to a direction of travel of the rail vehicle, wherein pivot axes (5.1, 6.1) of the upper and lower joint regions (5, 6) of the posts are rotated relative to each other such that they intersect in a vertical axis of rotation which, in relation to a transverse direction transverse to the side wall, is located closer to a vehicle centre of the rail vehicle than to the side wall, and - a second connection component (11, 12, 14, 15), which is fixed to the table top at a distance from the first connection component (3, 5, 6), characterized in that this second connection component is designed to couple the table top to the side wall so that, in relation to a state of the apparatus arranged on the side wall, in the event of an occurrence of a force acting on the table top in the direction of travel of the rail vehicle, a torque can be transmitted to the side wall by means of the first connection component (3, 5, 6) and the second connection component (11, 12, 14, 15), independently of each other, wherein, in relation to a respective longitudinal axis of the posts, the respective lower joint regions are designed to be narrower than the upper joint regions. - a table top, - a first connection component (3, 5, 6), which is arranged underneath an upper side (1.1) of the table top as a supporting structure and the upper end of which is fixed to the table top and the lower end of which is fixed to the side wall of the rail vehicle, wherein the first connection component (3, 5, 6) comprises two posts which are arranged upright at a distance from each other and each have a lower, first joint region and an upper, second joint region, which can be pivoted about a respective pivot axis (5.1, 6.1) and which, in relation to a state of the apparatus arranged on the side wall, are each oriented transversely to a direction of travel of the rail vehicle, wherein pivot axes (5.1, 6.1) of the upper and lower joint regions (5, 6) of the posts are rotated relative to each other such that they intersect in a vertical axis of rotation which, in relation to a transverse direction transverse to the side wall, is located closer to a vehicle centre of the rail vehicle than to the side wall, and - a second connection component (11, 12, 14, 15), which is fixed to the table top at a distance from the first connection component (3, 5, 6),
A method of using a volatile antimicrobial compound against pathogens affecting meats, plants, or plant parts, comprising providing a volatile antimicrobial compound of formula: wherein A and D together with the carbon atoms to which they are attached form a 5-, 6-, or 7-membered fused ring which may be substituted by C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxy, halogen, nitro, nitrile, amino, amino substituted by one or more C 1 -C 6 -alkyl groups, carboxy, acyl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, sulfonamido or trifluoromethyl or the fused ring may link two oxaborole rings; X is a group -CR 7 R 8 wherein R 7 and R 8 are each independently hydrogen, C 1 -C 6 -alkyl, nitrile, nitro, aryl, arylalkyl or R 7 and R 8 together with the carbon atom to which they are attached form an alicyclic ring; and R 6 is hydrogen, C 1 -C 18 -alkyl, C 1 -C 18 -alkyl substituted by C 1 -C 6 -alkoxy, C 1 -C 6 alkylthio, hydroxy, amino, amino substituted by C 1 -C 18 -alkyl, carboxy, aryl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, aryl or arylalkyl, arylalkyl, aryl, heteroaryl, cycloalkyl, C 1 -C 18 -alkyleneamino, C 1 -C 18 -alkyleneamino substituted by phenyl, C 1 -C 6 -alkoxy or C 1 -C 6 -alkylthio, carbonyl alkyleneamino or a radical of formula: wherein A, D and X are as defined herein before except for boronophthalide; and agriculturally acceptable salts thereof; and contacting a meat, plant, or plant part with an effective amount of the volatile antimicrobial compound, wherein said contacting comprises applying the volatile antimicrobial compound by way of gas treatment. wherein A and D together with the carbon atoms to which they are attached form a 5-, 6-, or 7-membered fused ring which may be substituted by C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxy, halogen, nitro, nitrile, amino, amino substituted by one or more C 1 -C 6 -alkyl groups, carboxy, acyl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, sulfonamido or trifluoromethyl or the fused ring may link two oxaborole rings; X is a group -CR 7 R 8 wherein R 7 and R 8 are each independently hydrogen, C 1 -C 6 -alkyl, nitrile, nitro, aryl, arylalkyl or R 7 and R 8 together with the carbon atom to which they are attached form an alicyclic ring; and R 6 is hydrogen, C 1 -C 18 -alkyl, C 1 -C 18 -alkyl substituted by C 1 -C 6 -alkoxy, C 1 -C 6 alkylthio, hydroxy, amino, amino substituted by C 1 -C 18 -alkyl, carboxy, aryl, aryloxy, carbonamido, carbonamido substituted by C 1 -C 6 -alkyl, aryl or arylalkyl, arylalkyl, aryl, heteroaryl, cycloalkyl, C 1 -C 18 -alkyleneamino, C 1 -C 18 -alkyleneamino substituted by phenyl, C 1 -C 6 -alkoxy or C 1 -C 6 -alkylthio, carbonyl alkyleneamino or a radical of formula: wherein A, D and X are as defined herein before except for boronophthalide; and agriculturally acceptable salts thereof; and contacting a meat, plant, or plant part with an effective amount of the volatile antimicrobial compound, wherein said contacting comprises applying the volatile antimicrobial compound by way of gas treatment.